KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 249 filers reported holding KARUNA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.56 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $119,373,329 | +94.3% | 377,155 | +3.8% | 0.05% | +76.9% |
| Q3 2023 | $61,441,895 | -26.2% | 363,368 | -5.4% | 0.03% | -23.5% |
| Q2 2023 | $83,262,160 | -26.8% | 383,962 | -38.7% | 0.03% | -30.6% |
| Q1 2023 | $113,741,152 | -0.8% | 626,190 | +7.3% | 0.05% | -5.8% |
| Q4 2022 | $114,634,563 | -3.0% | 583,382 | +11.0% | 0.05% | -8.8% |
| Q3 2022 | $118,198,000 | +638.0% | 525,490 | +315.1% | 0.06% | +714.3% |
| Q2 2022 | $16,015,000 | +184.7% | 126,592 | +185.3% | 0.01% | +250.0% |
| Q1 2022 | $5,625,000 | -3.0% | 44,364 | +0.2% | 0.00% | 0.0% |
| Q4 2021 | $5,799,000 | +7.1% | 44,264 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $5,415,000 | +2.4% | 44,264 | -4.6% | 0.00% | 0.0% |
| Q2 2021 | $5,288,000 | +5.6% | 46,394 | +11.4% | 0.00% | 0.0% |
| Q1 2021 | $5,009,000 | +18.3% | 41,664 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $4,233,000 | +79.4% | 41,664 | +36.5% | 0.00% | +100.0% |
| Q3 2020 | $2,360,000 | -35.8% | 30,524 | -7.5% | 0.00% | -50.0% |
| Q2 2020 | $3,676,000 | +180.8% | 32,983 | +81.4% | 0.00% | +100.0% |
| Q1 2020 | $1,309,000 | +101.1% | 18,183 | +110.5% | 0.00% | – |
| Q4 2019 | $651,000 | – | 8,640 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 782,008 | $142,043,933 | 58.49% |
| Nan Fung Group Holdings Ltd | 225,688 | $40,993,968 | 27.90% |
| Sofinnova Investments, Inc. | 1,773,124 | $322,070,243 | 20.60% |
| Artia Global Partners LP | 88,831 | $16,135,263 | 5.96% |
| DAFNA Capital Management LLC | 78,573 | $14,272,000 | 4.28% |
| First Light Asset Management, LLC | 243,675 | $44,261,127 | 3.98% |
| Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. | 47,376 | $8,605,377 | 3.04% |
| CATALYST PRIVATE WEALTH, LLC | 21,837 | $3,966,473 | 2.74% |
| Sands Capital Ventures, LLC | 58,895 | $10,697,688 | 2.64% |
| ARCH Venture Management, LLC | 30,000 | $5,449,200 | 2.63% |